PATENT CLAIM ANALYSIS

Application Number: 16239950
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-04
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to the novel long non-coding BARD1 RNA molecule BARD1 9′L, siRNAs for therapeutic use and methods for the detection of BARD1 9′L as well as a promoters driving the expression of BARD1 9′L.

Claim (Index 7):
A method of screening for compounds, optionally siRNA, useful in the prevention or treatment of cancer wherein i. the compounds are applied to cells expressing BARD1 9\u2032L, ii. measuring with known techniques FL BARD1 and BARD1 isoforms wherein their level of expression is indicative of the usefulness of the compound in the prevention or treatment of cancer.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14797148', '13817013', '15553097', '12430737', '14988275']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7467069386700411
- 35 USC 102 Novelty (BERT): 0.5994005515705346
- Combined Prediction Score: 0.7319762999600905
- Mean Citation Score: 341.78225
- Max Citation Score: 598.1582599999998
- Similarity Product: 402.30618293503386

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test